TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.
de Witte MA, Bendle GM, van den Boom MD, Coccoris M, Schell TD, Tevethia SS, van Tinteren H, Mesman EM, Song JY, Schumacher TN.
de Witte MA, et al. Among authors: schumacher tn.
J Immunol. 2008 Aug 15;181(4):2563-71. doi: 10.4049/jimmunol.181.4.2563.
J Immunol. 2008.
PMID: 18684947
Free PMC article.